Funder: Alzheimer's Drug Discovery Foundation
Due Dates: January 12, 2026 (Invited full proposal) | September 14, 2026 (Letter of Intent)
Funding Amounts: Up to $5,000,000 per clinical trial; multi-year awards; only direct costs allowed.
Summary: Supports human studies on prevention, combination therapy, and comparative effectiveness research to reduce Alzheimer’s and dementia risk by targeting key biological mechanisms.
Key Information: Funding is provided as mission-related investments with ROI requirements based on milestones.